John M. Brandow

Davis Polk advised an ad hoc group of noteholders in connection with their private exchange with Denbury Resources Inc. of approximately $364 million aggregate principal amount of 5.50%…

Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Workday, Inc. of $1.15 billion aggregate principal amount of its 0.25%…

Davis Polk advised the representatives of the underwriters in connection with an SEC-registered offering of 11,000,000 shares of common stock of XPO Logistics, Inc. and advised the…

Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by RealPage, Inc. of $345 million aggregate principal amount of its 1.50%…

Davis Polk advised the initial purchasers in connection with a Rule 144A offering by Evolent Health, Inc. of $125 million aggregate principal amount of its 2.00% senior convertible notes…

Davis Polk advised the underwriters on a registered shelf takedown of 28,500,000 American depositary shares. The total proceeds of the shelf takedown were approximately $1.3 billion. Ctrip…

Davis Polk advised the initial purchasers in a Rule 144A and Regulation S offering by Ctrip.com International, Ltd. of $900 million aggregate principal amount of 1.25% convertible notes due…

Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Inphi Corporation of $287.5 million aggregate principal amount of its 0.75%…

Davis Polk acted as special product counsel to the representatives of the initial purchasers in connection with an SEC-registered offering by Intercept Pharmaceuticals, Inc. of an aggregate…

Davis Polk advised the joint bookrunners in connection with a Rule 144A offering by The Medicines Company of $402.5 million aggregate principal amount of 2.75% convertible senior notes due…